Perhaps the report on China’s strategy for eclipsing the U.S. lead in biopharma from the Information Technology & Innovation Foundation (ITIF) resonated so strongly with me because of several articles in The Wall Street Journal. Taken together, they present a sobering picture of what we’re up against. The first was a book review of “Leadership and the Rise of Great Powers” by Yan Xuetong, a prominent Chinese professor. Characterized as “a window into Chinese elite thinking about the world; it is as much a political manual as an international-relations text book.” The thesis is the inevitable rise of China as the world’s dominant power at the expense of the United States.
Business
- This Week in D.C.: NASA Deep Space Exploration, Small Business and Innovation, and Transportation Sustainability
- Chief Judge Paul Michel: Patent Reform Progress is Likely, But We Must Stay Focused On the Big Picture
- Take Steps to Deter the Spy in Your Business
- Don’t Ignore the Flashing Caution Lights in the Drug Pricing Debate
- Proving a Negative Claim Limitation: A Tale of Three Nonprecedential Cases
Recent Posts
- This Week in D.C.: NASA Deep Space Exploration, Small Business and Innovation, and Transportation Sustainability
- Chief Judge Paul Michel: Patent Reform Progress is Likely, But We Must Stay Focused On the Big Picture
- Take Steps to Deter the Spy in Your Business
- Russia: Court Removes Candidate from Ballot for Social Network Post
- Don’t Ignore the Flashing Caution Lights in the Drug Pricing Debate